Abrdn PLC 89bio, Inc. Transaction History
Abrdn PLC
- $53.3 Billion
- Q3 2024
A detailed history of Abrdn PLC transactions in 89bio, Inc. stock. As of the latest transaction made, Abrdn PLC holds 470,387 shares of ETNB stock, worth $3.62 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
470,387
Previous 470,387
-0.0%
Holding current value
$3.62 Million
Previous $3.77 Million
7.62%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ETNB
# of Institutions
159Shares Held
108MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$117 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$109 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$61.5 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$56.7 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$53.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $357M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...